Home
About us
Management Team
Technology
News
Publications
Careers
Contact


Axerion Therapeutics, Inc.is a biotechnology company that is developing disease-modifying therapeutics for the management and treatment of spinal cord injury (SCI) and glaucoma.

With its Nogo Receptor platform, Axerion is developing treatments that have the potential to stimulate regrowth in axons, which are long cellular fibers that electrically connect one nerve cell to another and play a vital role in supporting neurological function. These potential treatments could help to restore function in patients who are suffering from spinal cord injuries, stroke and other central nervous system disorders.